![](/img/cover-not-exists.png)
Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutations
Shen, Yi-Cheng, Tseng, Guan-Chin, Tu, Chih-Yeh, Chen, Wei-Chun, Liao, Wei-Chih, Chen, Wei-Cheng, Li, Chia-Hsiang, Chen, Hung-Jen, Hsia, Te-ChunVolume:
110
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2017.06.007
Date:
August, 2017
File:
PDF, 439 KB
english, 2017